EFFICACY AND SAFETY OF PREDNISOLONE IN ACUTE PULMONARY EXACERBATION OF CYSTIC FIBROSIS: A RANDOMISED CONTROLLED TRIAL - NI

Post Graduate Institute of Medical Education and Research Chandigardh0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1)Confirmed diagnosis of cystic fibrosis based on:
•Newborn screening or at least one clinical feature of CF, AND either (a) or (b) as follows:
•a) Documented sweat chloride = 60 mEq/L by quantitative pilocarpine iontophoresis
•b)Genotype with two identifiable CF-causing mutations.
•2)Age > 6 years old.
•3)Acute pulmonary exacerbation as per Fuchs criteria

•1)Active allergic bronchopulmonary aspergillosis (ABPA) at the time of enrollment as determined by the treating physician.
•2)Uncontrolled hypertension with suspected end organ damage
•3)Physical findings that could potentially compromise the safety of the participant or the quality of the study data as determined by site investigator.
•4)Children enrolled in the study within the preceding twelve months.

发起方

Post Graduate Institute of Medical Education and Research Chandigardh